Stockbabie NewsFatherMarketNewsMarket Intelligence
Subscribe
MARKETS
Wire · Earnings
Earnings

Aurinia Pharmaceuticals Affirms FY2026 Sales Guidance of $315.000M-$325.000M vs $323.065M Est

Aug 6, 2026 · 08:41 AM ET· updated 2h ago

Aurinia Pharmaceuticals (NASDAQ:AUPH) affirms FY2026 sales outlook from $315.000 million-$325.000 million to $315.000 million-$325.000 million vs $323.065 million estimate.

Share
Why It Matters

Aurinia said their sales prediction for next year stays the same—between $315 million and $325 million. This shows the company feels confident their business plan is on track, even though it's a pretty narrow range.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
AUPH15.84
+0.65 (+4.30%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.